Clinical Trial 39861


Indianapolis, IN 46112

Study Summary:

Phase2 study for 52 weeks, study comparing the efficacy and safety of Brazikumab to placebo in the treatment of patients with symptoms of moderate to severe Active Ulerative Colitis. 

Qualified Participants Must:

• Have diagnosis of Severe Active Ulcerative Colitis
• Be 16-80 years old

Qualified Participants May Receive:

Study medication for Ulcerative Colitis, Colonoscopies, study supplies, study exams and compensation for time and travel.

Study is Available At:

Investigators Research Group, LLC
321 E. Northfield Drive, Suite 100
Indianapolis, IN 46112
View Clinic Location


If you or someone you care for is interested in participating in this clinical trial and lives within 50 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.